{"id":"W1963635957","doi":"10.1310/hct0902-73","title":"Efficacy and Safety of 48 Weeks of Enfuvirtide 180 mg Once-Daily Dosing Versus 90 mg Twice-Daily Dosing in HIV-Infected Patients","year":2008,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Enfuvirtide; Dosing; Regimen; Adverse effect; Pharmacokinetics; Internal medicine; Pharmacology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001032363,0.0006911956,0.001455093,0.0002148054,0.0002654575,0.0005268561,0.0004099237,0.000958864,0.002700126],"category_scores_gemma":[0.001782979,0.0004115067,0.0008215036,0.000161246,0.0004155439,0.0007954543,0.0002240239,0.001227255,0.0003991246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004538272,"about_ca_system_score_gemma":0.0004203393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004039728,"about_ca_topic_score_gemma":0.0007126691,"domain_scores_codex":[0.9994917,0.0002545914,0.00003640226,0.0001018021,0.00005525304,0.00006013067],"domain_scores_gemma":[0.9991504,0.0002192101,0.0003048322,0.00005645237,0.00003504786,0.000234089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8528908,0.01596191,0.006727071,0.0003905777,0.0005276569,0.00009636961,0.0001471467,0.00103975,0.01728689,0.00007872468,0.0006359761,0.104217],"study_design_scores_gemma":[0.259198,0.6858124,0.04627126,0.00006519536,0.0005975053,0.0002550217,0.00009242097,0.002406914,0.003978084,0.0001977151,0.001071686,0.00005386108],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977349,0.001339022,0.0001001603,0.00009988438,0.00003677935,0.0001261001,0.000100265,0.0000236702,0.0004392072],"genre_scores_gemma":[0.9985228,0.0003402083,0.0002770515,0.0001440505,0.00005394625,0.0001620777,0.0001155262,0.000004476122,0.0003799202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002700126,"threshold_uncertainty_score":0.009032786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1454580302820737,"score_gpt":0.408940599363976,"score_spread":0.2634825690819023,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}